Preventable spina bifida and anencephaly in Europe

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 103, Issue 9, 2015, Pages 763-771

  Obeid, Rima ^a   Pietrzik, Klaus ^b   Oakley, Godfrey P ^c   Kancherla, Vijaya ^c   Holzgreve, Wolfgang ^d   Wieser, Simon ^e  

^a AARHUS UNIVERSITY   (Denmark)

^b UNIVERSITY OF BONN   (Germany)

^c EMORY UNIVERSITY   (United States)

^d UNIVERSITY HOSPITAL BONN   (Germany)

^e ZURICH UNIVERSITY OF APPLIED SCIENCES   (Switzerland)

Author keywords

Anencephaly; Economic; Folic acid; Fortification; Neural tube defects; Pregnancy; Prevention; Spina bifida

Indexed keywords

FOLIC ACID;

ANENCEPHALUS; ARTICLE; CONTROLLED STUDY; COST CONTROL; EUROPE; GERMANY; HEALTH CARE COST; HUMAN; LIVE BIRTH; MAJOR CLINICAL STUDY; NEURAL TUBE DEFECT; PREGNANCY; PREVALENCE; PRIMARY PREVENTION; PRIORITY JOURNAL; RISK REDUCTION; SPINAL DYSRAPHISM; ANENCEPHALY; CAUCASIAN; DIETARY SUPPLEMENT; ETHNIC GROUP; FEMALE; FORTIFIED FOOD;

ANENCEPHALY; DIETARY SUPPLEMENTS; ETHNIC GROUPS; EUROPE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLIC ACID; FOOD, FORTIFIED; HUMANS; LIVE BIRTH; PREGNANCY; PREVALENCE; SPINAL DYSRAPHISM;

EID: 84941087792     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.23400     Document Type: Article

References (51)

1. Barbour RS, Macleod M, Mires G, Anderson AS. 2012. Uptake of folic acid supplements before and during pregnancy: focus group analysis of women's views and experiences. J Hum Nutr Diet 25:140-147.
2. Berti C, Fekete K, Dullemeijer C, et al. 2012. Folate intake and markers of folate status in women of reproductive age, pregnant and lactating women: a meta-analysis. J Nutr Metab 2012;2012:470656.
3. Berry RJ, Bailey L, Mulinare J, et al. 2010. Fortification of flour with folic acid. Food Nutr Bull 31(Suppl):S22-S35.
4. Bestwick JP, Huttly WJ, Morris JK, Wald NJ. 2014. Prevention of neural tube defects: a cross-sectional study of the uptake of folic acid supplementation in nearly half a million women. PLoS One 9:e89354.
5. Bitzer J, von Stenglin A, Bannemerschult R. 2013. Women's awareness and periconceptional use of folic acid: data from a large European survey. Int J Womens Health 5:201-213.
6. Blencowe A, Cousens S, Modell B, Lawn J. 2010. Folic acid to reduce neonatal mortality from neural tube disorders. Int J Epidemiol 39:i110-i121.
7. Bowles D, Wasiak R, Kissner M, et al. 2014. Economic burden of neural tube defects in Germany. Public Health 128:274-281.
8. Bramswig S, Prinz-Langenohl R, Lamers Y, et al. 2009. Supplementation with a multivitamin containing 800 microg of folic acid shortens the time to reach the preventive red blood cell folate concentration in healthy women. Int J Vitam Nutr Res 79:61-70.
9. Busby A, Abramsky L, Dolk H, et al. 2005. Preventing neural tube defects in Europe: a missed opportunity. Reprod Toxicol 20:393-402.
10. CDC. 2010. CDC Grand Rounds: additional opportunities to prevent neural tube defects with folic acid fortification. MMWR Morb Mortal Wkly Rep 59:980-984.
11. Colapinto CK, Tremblay MS, Aufreiter S, et al. 2014. The direction of the difference between Canadian and American erythrocyte folate concentrations is dependent on the assay method employed: a comparison of the Canadian Health Measures Survey and National Health and Nutrition Examination Survey. Br J Nutr 112:1873-1881.
12. Crider KS, Devine O, Hao L, et al. 2014. Population red blood cell folate concentrations for prevention of neural tube defects: Bayesian model. BMJ 349:g4554.
13. Czeizel AE, Dudas I. 1992. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 327:1832-1835.
14. Daly S, Mills JL, Molloy AM, et al. 1997. Minimum effective dose of folic acid for food fortification to prevent neural-tube defects. Lancet 350:1666-1669.
15. De-Regil LM, Fernandez-Gaxiola AC, Dowswell T, Pena-Rosas JP. 2010. Effects and safety of periconceptional folate supplementation for preventing birth defects. Cochrane Database Syst Rev (10):CD007950.
16. De Wals P, Tairou F, Van Allen MI, et al. 2008. Spina bifida before and after folic acid fortification in Canada. Birth Defects Res A Clin Mol Teratol 82:622-626.
17. EUROCAT. (2015). EUROCAT Website Database. Available at: http://www.eurocat-network.eu/ACCESSPREVALENCEDATA/PrevalenceTables. Accessed May 11, 2015.
18. Greenlees R, Neville A, Addor MC, et al. 2011. Paper 6: EUROCAT member registries: organization and activities. Birth Defects Res A Clin Mol Teratol 91:S51-S100.
19. Huo Y, Li J, Qin X, et al. 2015. Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: the CSPPT randomized clinical trial. JAMA 313:1325-1335.
20. Jentink J, van de Vrie-Hoekstra NW, de Jong-van den Berg LT, Postma MJ. 2008. Economic evaluation of folic acid food fortification in The Netherlands. Eur J Public Health 18:270-274.
21. Kancherla V, Druschel CM, Oakley GP Jr. 2014. Population-based study to determine mortality in spina bifida: New York State Congenital Malformations Registry, 1983 to 2006. Birth Defects Res A Clin Mol Teratol 100:563-575.
22. Kinsman SL, Doehring MC. 1996. The cost of preventable conditions in adults with spina bifida. Eur J Pediatr Surg 6:17-20.
23. Kirsch SH, Herrmann W, Kruse V, et al. 2014. One year B-vitamins increases serum and whole blood folate forms and lowers plasma homocysteine in older Germans. Clin Chem Lab Med 53:445-452.
24. Krauth C, Jalilvand N, Welte T, Busse R. 2003. Cystic fibrosis: cost of illness and considerations for the economic evaluation of potential therapies. Pharmacoeconomics 21:1001-1024.
25. Lamers Y, Prinz-Langenohl R, Bramswig S, Pietrzik K. 2006. Red blood cell folate concentrations increase more after supplementation with [6S]-5-methyltetrahydrofolate than with folic acid in women of childbearing age. Am J Clin Nutr 84:156-161.
26. Maher M, Keriakos R. 2014. Women's awareness of periconceptional use of folic acid before and after their antenatal visits. Clin Med Insights Womens Health 7:9-15.
27. Medical Research Council. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet 1991;338:131e7.
28. Miller EC, Liu N, Wen SW, Walker M. 2011. Why do Canadian women fail to achieve optimal pre-conceptional folic acid supplementation? An observational study. J Obstet Gynaecol Can 33:1116-1123.
29. Milunsky A, Jick H, Jick SS, et al. 1989. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA 262:2847-2852.
30. Mulinare J, Cordero JF, Erickson JD, Berry RJ. 1988. Periconceptional use of multivitamins and the occurrence of neural tube defects. JAMA 260:3141-3145.
31. Oakeshott P, Hunt GM, Poulton A, Reid F. 2010. Expectation of life and unexpected death in open spina bifida: a 40-year complete, non-selective, longitudinal cohort study. Dev Med Child Neurol 52:749-753.
32. Obeid R, Koletzko B, Pietrzik K. 2014. Critical evaluation of lowering the recommended dietary intake of folate. Clin Nutr 33:252-259.
33. Obeid R, Oexle K, Rißmann A, et al. 2015. Folate status and health: challenges and oppurtunities. J Perinat Med doi: 10.1515/jpm-2014-0346 [Epub ahead of print].
34. Odewole OA, Williamson RS, Zakai NA, et al. 2013. Near-elimination of folate-deficiency anemia by mandatory folic acid fortification in older US adults: reasons for geographic and racial differences in stroke study 2003-2007. Am J Clin Nutr 98:1042-1047.
35. OECD. 2011. Health at a Glance 2011: OECD Indicators, OECD Publishing. Available at: http://dx doi org/10 1787/health_glance-2011-en 2011.
36. Ouyang L, Grosse SD, Armour BS, Waitzman NJ. 2007. Health care expenditures of children and adults with spina bifida in a privately insured U.S. population. Birth Defects Res A Clin Mol Teratol 79:552-558.
37. Pachón H, Kancherla V, Handforth B, et al. 2013. Folic acid fortification of wheat flour: a cost-effective public health intervention to prevent birth defects in Europe. Nutr Bull 38:201-209.
38. Pfeiffer CM, Caudill SP, Gunter EW, et al. 2005. Biochemical indicators of B vitamin status in the US population after folic acid fortification: results from the National Health and Nutrition Examination Survey 1999-2000. Am J Clin Nutr 82:442-450.
39. Pfeiffer CM, Johnson CL, Jain RB, et al. 2007. Trends in blood folate and vitamin B-12 concentrations in the United States, 1988 2004. Am J Clin Nutr 86:718-727.
40. Pfeiffer CM, Hughes JP, Durazo-Arvizu RA, et al. 2012. Changes in measurement procedure from a radioassay to a microbiologic assay necessitate adjustment of serum and RBC folate concentrations in the U.S. population from the NHANES 1988-2010. J Nutr 142:894-900.
41. Rofail D, Colligs A, Abetz L, et al. 2012. Factors contributing to the success of folic acid public health campaigns. J Public Health (Oxf) 34:90-99.
42. Smith MA, Lau C. 2015. A resolution on folic acid fortification. Birth Defects Res A Clin Mol Teratol 103:1-2.
43. Smithells RW, Nevin NC, Seller MJ, et al. 1983. Further experience of vitamin supplementation for prevention of neural tube defect recurrences. Lancet 1:1027-1031.
44. Steenweg-de Graaff J, Roza SJ, Steegers EA, et al. 2012. Maternal folate status in early pregnancy and child emotional and behavioral problems: the Generation R Study. Am J Clin Nutr 95:1413-1421.
45. van Gool K, Norman R, Delatycki MB, et al. 2013. Understanding the costs of care for cystic fibrosis: an analysis by age and health state. Value Health 16:345-355.
46. Waitzman NJ, Scheffler RM, Romano PS. 1996. The cost of birth defects: estimates of the value of prevention. Lanham: University Press of America.
47. Wald NJ, Law MR, Morris JK, Wald DS. 2001. Quantifying the effect of folic acid. Lancet 358:2069-2073.
48. Wang Y, Hu J, Druschel CM. 2010. A retrospective cohort study of mortality among children with birth defects in New York State, 1983-2006. Birth Defects Res A Clin Mol Teratol 88:1023-1031.
49. World Health Organization. 2015. Optimal serum and red blood cell folate concentrations in women of reproductive age for prevention of neural tube defects, Guideline. ISBN: 978-92-4-154904-2.
50. Williams J, Mai CT, Mulinare J, Lanham 2015. Updated estimates of neural tube defects prevented by mandatory folic Acid fortification - United States, 1995-2011. MMWR Morb Mortal Wkly Rep 64:1-5.
51. Yi Y, Lindemann M, Colligs A, Snowball C. 2011. Economic burden of neural tube defects and impact of prevention with folic acid: a literature review. Eur J Pediatr 170:1391-1400.